CAD 0.24
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 1.8 Million CAD | -43.81% |
2022 | 3.2 Million CAD | 93.1% |
2021 | 1.66 Million CAD | -14.23% |
2020 | 1.93 Million CAD | 52.48% |
2019 | 1.27 Million CAD | 8701.09% |
2018 | 14.44 Thousand CAD | 0.0% |
2017 | - CAD | -100.0% |
2016 | 110 Thousand CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 1.56 Million CAD | -11.38% |
2024 Q1 | 1.76 Million CAD | -1.97% |
2023 Q4 | 1.8 Million CAD | -15.49% |
2023 FY | 1.8 Million CAD | -43.81% |
2023 Q3 | 2.13 Million CAD | 21.63% |
2023 Q2 | 1.75 Million CAD | -2.96% |
2023 Q1 | 1.8 Million CAD | -43.67% |
2022 Q1 | 2.53 Million CAD | 52.77% |
2022 FY | 3.2 Million CAD | 93.1% |
2022 Q4 | 3.2 Million CAD | 17.3% |
2022 Q3 | 2.73 Million CAD | 2.22% |
2022 Q2 | 2.67 Million CAD | 5.43% |
2021 Q3 | 1.78 Million CAD | 241.81% |
2021 FY | 1.66 Million CAD | -14.23% |
2021 Q2 | 522.81 Thousand CAD | -28.95% |
2021 Q1 | 735.87 Thousand CAD | -62.03% |
2021 Q4 | 1.66 Million CAD | -6.99% |
2020 Q2 | 1.2 Million CAD | -2.58% |
2020 FY | 1.93 Million CAD | 52.48% |
2020 Q1 | 1.23 Million CAD | -2.48% |
2020 Q4 | 1.93 Million CAD | 64.88% |
2020 Q3 | 1.17 Million CAD | -2.66% |
2019 Q2 | 1.33 Million CAD | 92.27% |
2019 FY | 1.27 Million CAD | 8701.09% |
2019 Q1 | 693.11 Thousand CAD | 4699.6% |
2019 Q3 | 1.3 Million CAD | -2.3% |
2019 Q4 | 1.27 Million CAD | -2.38% |
2018 Q1 | - CAD | 0.0% |
2018 Q4 | 14.44 Thousand CAD | -3.7% |
2018 Q3 | 14.99 Thousand CAD | 0.0% |
2018 FY | 14.44 Thousand CAD | 0.0% |
2017 FY | - CAD | -100.0% |
2017 Q4 | - CAD | 0.0% |
2016 FY | 110 Thousand CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Aurora Cannabis Inc. | 104.79 Million CAD | 98.279% |
Avant Brands Inc. | 18.7 Million CAD | 90.357% |
Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -1037.56% |
Crescita Therapeutics Inc. | 1.25 Million CAD | -43.812% |
Knight Therapeutics Inc. | 69.09 Million CAD | 97.39% |
MediPharm Labs Corp. | 2.29 Million CAD | 21.421% |
OrganiGram Holdings Inc. | 155 Thousand CAD | -1063.482% |
Canopy Growth Corporation | 683.17 Million CAD | 99.736% |
Willow Biosciences Inc. | 2.15 Million CAD | 16.354% |
Auxly Cannabis Group Inc. | 159.04 Million CAD | 98.866% |